These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30969931)

  • 1. Capsule Network Based Modeling of Multi-omics Data for Discovery of Breast Cancer-Related Genes.
    Peng C; Zheng Y; Huang DS
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1605-1612. PubMed ID: 30969931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NNBGWO-BRCA marker: Neural Network and binary grey wolf optimization based Breast cancer biomarker discovery framework using multi-omics dataset.
    Li M; Cai Y; Zhang M; Deng S; Wang L
    Comput Methods Programs Biomed; 2024 Sep; 254():108291. PubMed ID: 38909399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.
    Colak D; Nofal A; Albakheet A; Nirmal M; Jeprel H; Eldali A; Al-Tweigeri T; Tulbah A; Ajarim D; Malik OA; Inan MS; Kaya N; Park BH; Bin Amer SM
    PLoS One; 2013; 8(5):e63204. PubMed ID: 23704896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data.
    Rashid MM; Selvarajoo K
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38904542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
    Lin Y; Zhang W; Cao H; Li G; Du W
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration.
    Seal DB; Das V; Goswami S; De RK
    Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
    Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M
    PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery.
    Lan W; Liao H; Chen Q; Zhu L; Pan Y; Chen YP
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38678587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification.
    Guo H; Lv X; Li Y; Li M
    Brief Funct Genomics; 2023 Nov; 22(5):463-474. PubMed ID: 37114942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
    Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
    Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer.
    Kim SY; Kim TR; Jeong HH; Sohn KA
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):68. PubMed ID: 30255812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer.
    Wang L; Yu L; Shi J; Li F; Zhang C; Xu H; Yin X; Wang L; Lin S; Litvinova A; Ping Y; Ning S; Zhao H
    Sci Rep; 2022 Jun; 12(1):10641. PubMed ID: 35739271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach.
    Srihari S; Kalimutho M; Lal S; Singla J; Patel D; Simpson PT; Khanna KK; Ragan MA
    Mol Biosyst; 2016 Mar; 12(3):963-72. PubMed ID: 26805938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.